{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -2.5641062, "regularMarketPrice": 0.95, "earningsTimestamp": 1678395600, "earningsTimestampStart": 1678395600, "earningsTimestampEnd": 1678395600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.7, "sharesOutstanding": 57883600, "bookValue": 1.201, "fiftyDayAverage": 0.917908, "fiftyDayAverageChange": 0.032091975, "fiftyDayAverageChangePercent": 0.03496208, "twoHundredDayAverage": 1.4543055, "twoHundredDayAverageChange": -0.50430554, "twoHundredDayAverageChangePercent": -0.34676725, "marketCap": 62092000, "priceToBook": 0.7910075, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1642748400000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "ENOCHIAN BIOSCI. DL-,0001", "longName": "Enochian Biosciences Inc.", "messageBoardId": "finmb_549849556", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.025000036, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.95, "regularMarketDayRange": "0.945 - 0.95", "regularMarketDayLow": 0.945, "regularMarketVolume": 3000, "regularMarketPreviousClose": 0.975, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.945, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.22499996, "fiftyTwoWeekLowChangePercent": 0.31034476, "fiftyTwoWeekRange": "0.725 - 6.13", "fiftyTwoWeekHighChange": -5.1800003, "fiftyTwoWeekHighChangePercent": -0.8450245, "fiftyTwoWeekLow": 0.725, "fiftyTwoWeekHigh": 6.13, "symbol": "2Q5.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Century City Medical Plaza", "address2": "Suite 906 2080 Century Park East", "city": "Los Angeles", "state": "CA", "zip": "90067-2012", "country": "United States", "phone": "305 918 1980", "website": "https://www.enochianbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was incorporated in 2017 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark R. Dybul M.D.", "age": 58, "title": "CEO, Director & Member of HBV Scientific Advisory Board", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 950000, "fmt": "950k", "longFmt": "950,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Luisa  Puche", "age": 58, "title": "CFO & Corp. Sec.", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 403750, "fmt": "403.75k", "longFmt": "403,750"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Serhat  G\u00fcmr\u00fckc\u00fc", "title": "Co-Founder & Inventor", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Francois  Binette M.Sc., Ph.D.", "age": 58, "title": "Chief Operating Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Evelyn  D'An", "age": 59, "title": "Consultant", "yearBorn": 1963, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Greg  Duczynski Ph.D.", "title": "Sr. VP for Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}